Institute for Translational Medicine
The University of Chicago Institute for Translational Medicine (ITM) is a member of the National Institutes of Health (NIH) Clinical and Translational Science Awards (CTSA) consortium that helps convert biomedical research into health improvement.
During the last eight years, the ITM has connected more than 1,800 researchers and community organizations with funding, training, and other resources while forging connections across departments, universities, and patient advocacy groups.
Since its 2007 inception, total funding for the ITM has exceeded $60 million through the NIH’s National Center for Advancing Translational Sciences (NCATS) CTSA grant numbers UL1 TR000430, KL2 TR000431, and TL1 TR000432, and from the University of Chicago Medicine and Biological Sciences.
The ITM has awarded more than $5.7 million in Pilot Awards to researchers and more than $1.3 million to investigators to subsidize the cost of using sophisticated Core Facilities equipment and services.
It works with 62 institutions across the country as part of the CTSA consortium to advance medicine in innovative ways and transform research results into improved clinical practice.
The ITM also collaborates with researchers and clinicians across many disciplines at partner institutions, including:
- NorthShore University HealthSystem
- Argonne National Laboratory
- Illinois Institute of Technology
- Rush University Medical Center
- Communities on the South Side of Chicago and beyond.
Source: January 2015 slideshow presentation from the ITM’s annual External Advisory Board (EAB) Meeting.